You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三生製藥(01530.HK):向朱禎平有條件授出1000萬股新獎勵股份
格隆匯 09-08 23:02

格隆匯 9 月 8日丨三生製藥(01530.HK)宣佈,於2020年9月7日,董事會議決向朱禎平有條件授出1000萬股新獎勵股份,佔經擴大後公司股份約0.3916%。

朱禎平為公司原藥物研發總裁及首席科學官,以及目前為三生國健的董事、藥物研發總裁及首席科學家。

公司認為,吸引及挽留人才資源及業務關係的能力對我們的成功至關重要。推出該計劃旨在讓公司更具靈活性,以吸引及激勵人才及作出貢獻的人士,將其留在集團,並發展和加強其與本集團的關係。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account